DNAnexus and Twist Bioscience Collaborate to Provide Data Analysis Software for NGS Workflow Read more
AVROBIO Receives Orphan Drug Designation from the FDA for AVR-RD-05, a Gene Therapy for Mucopolysaccharidosis Type II (MPSII) or Hunter Syndrome Read more
Innoviva Sells 15% Economic Stake in Theravance Respiratory Company to Royalty Pharma for approximately $282 million plus full ownership of existing equity investments and the potential for $50 million milestone payment Read more
GenScript ProBio Signs MOU to Form Strategic Partnership with ACT Therapeutics to Development of New CAR-T Cell Therapies Read more
Bicycle Therapeutics Announces Further Expansion of Genentech Immuno-Oncology Collaboration Read more
Anthos Therapeutics Announces that Abelacimab has Received FDA Fast Track Designation for the Treatment of Thrombosis Associated with Cancer Read more